158 related articles for article (PubMed ID: 19663005)
1. [Potentiation of nitric oxide-dependent activation of soluble guanylate cyclase by levomycetin, tetracycline, and oxolin].
Shchegolev AIu; Sidorova TA; Severina IS
Biomed Khim; 2009; 55(3):331-7. PubMed ID: 19663005
[TBL] [Abstract][Full Text] [Related]
2. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome].
Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA
Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427
[TBL] [Abstract][Full Text] [Related]
3. [Potentiation of NO-dependent activation of soluble guanylyl cyclase by 5-nitroisatin and antiviral preparatation arbidol].
Severina IS; Shchegolev AIu; Medvedev AE
Biomed Khim; 2013; 59(3):295-304. PubMed ID: 23987067
[TBL] [Abstract][Full Text] [Related]
4. [Potentiation of NO-dependent activation of soluble guanylate cyclase by polyamines].
Severina IS; Piatakova NV; Shchegolev AIu
Biomed Khim; 2007; 53(1):44-9. PubMed ID: 17436683
[TBL] [Abstract][Full Text] [Related]
5. [Potentiation of activation of soluble guanylate cyclase by YC-1, NO-donors and increase of the synergistic effect of YC-1 on NO-dependent activation of the enzyme by 1,2,3-triazolyl-1,2,5-oxadiazole derivatives].
Severina IS; Pyatakova NV; Shchegolev AY; Rozhkov VY; Batog LV; Makhova NN
Biomed Khim; 2015; 61(6):705-11. PubMed ID: 26716741
[TBL] [Abstract][Full Text] [Related]
6. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
Severina IS
Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
[TBL] [Abstract][Full Text] [Related]
7. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
9. YC-1-like potentiation of NO-dependent activation of soluble guanylate cyclase by derivatives of protoporphyrin IX.
Severina IS; Pyatakova NV; Shchegolev AY; Ponomarev GV
Biochemistry (Mosc); 2006 Mar; 71(3):340-4. PubMed ID: 16545073
[TBL] [Abstract][Full Text] [Related]
10. [Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs].
Piatakova NV; Severina IS
Biomed Khim; 2012; 58(1):32-42. PubMed ID: 22642150
[TBL] [Abstract][Full Text] [Related]
11. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
[TBL] [Abstract][Full Text] [Related]
12. Antitumor antibiotic streptonigrin and its derivatives as inhibitors of nitric oxide-dependent activation of soluble guanylyl cyclase.
Severina IS; Pyatakova NV; Postnikov AB; Preobrazhenskaya MN; Khropov YV
Eur J Pharmacol; 2004 Jan; 483(2-3):127-32. PubMed ID: 14729099
[TBL] [Abstract][Full Text] [Related]
13. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1.
Nakane M; Hsieh G; Miller LN; Chang R; Terranova MA; Moreland RB; Kolasa T; Brioni JD
Int J Impot Res; 2002 Apr; 14(2):121-7. PubMed ID: 11979328
[TBL] [Abstract][Full Text] [Related]
14. YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase.
Wu CC; Kuo SC; Lee FY; Teng CM
Eur J Pharmacol; 1999 Sep; 381(2-3):185-91. PubMed ID: 10554886
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
Mol Pharmacol; 2003 Jun; 63(6):1322-8. PubMed ID: 12761342
[TBL] [Abstract][Full Text] [Related]
16. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
Severina IS
Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
[TBL] [Abstract][Full Text] [Related]
17. Analysis of nitric oxide-sensitive guanylyl cyclase in human platelets before and after aggregation.
Kempfert J; Behrends S
Platelets; 2003; 14(7-8):429-35. PubMed ID: 14713512
[TBL] [Abstract][Full Text] [Related]
18. YC-1, a novel activator of platelet guanylate cyclase.
Ko FN; Wu CC; Kuo SC; Lee FY; Teng CM
Blood; 1994 Dec; 84(12):4226-33. PubMed ID: 7527671
[TBL] [Abstract][Full Text] [Related]
19. Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase.
Severina IS; Bussygina OG; Pyatakova NV; Khropov YV; Krasnoperov RA
Eur J Pharmacol; 2000 Oct; 407(1-2):61-4. PubMed ID: 11050291
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
Bellamy TC; Garthwaite J
Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
